COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

30,496 Articles (22,363 medRxiv, 8,133 bioRxiv)

Most recent first Previous |  Page 185: Articles 1841-1850  | Next

Emergence and spread of SARS-CoV-2 variants from farmed mink to humans and back during the epidemic in Denmark, June-November 2020.
Rasmussen, T. B., Qvesel, A. G., Pedersen, A. G., Olesen, A. S., Fonager, J., Rasmussen, M., Sieber, R. N., Stegger, M., Artavia, F. F. C., Thuesen, E. R., Goedknegt, M. J. F., Lohse, L., Mortensen, S., Fomsgaard, A., Boklund, A. E., Botner, A., Belsham, G. J.
10.1101/2024.02.13.580053 — Posted: 2024-02-14
Mathematical assessment of the role of human behavior changes on SARS-CoV-2 transmission dynamics
Pant, B., Safdar, S., Santillana, M., Gumel, A.
10.1101/2024.02.11.24302662 — Posted: 2024-02-13
Association between altitude and death from COVID-19 in subjects with diabetes mellitus during the first wave: cross sectional study of the National Death Index
Ambrosio-Ojose, R. M., Casquero-Zambrano, C. J., Vasquez-Hassinger, T., Yovera-Aldana, M.
10.1101/2024.02.12.24302726 — Posted: 2024-02-13
Body mass index changes and their association with SARS-CoV-2 infection: a real-world analysis
Varghese, J. S., Guo, Y., Ali, M. K., Donahoo, W. T., Chakkalakal, R. J.
10.1101/2024.02.12.24302697 — Posted: 2024-02-13
SARS-CoV-2 virus in Raw Wastewater from Student Residence Halls with concomitant 16S rRNA Bacterial Community Structure changes
Li, Y., Aah, K. T., Joyner, D. C., Williams, D. E., Hazen, T. C.
10.1101/2024.02.11.24302582 — Posted: 2024-02-13
Restrained memory CD8+ T cell responses favors viral persistence and elevated IgG responses in patients with severe Long COVID.
Rodriguez, L., Tan, Z., Tadepally, L. K., Wang, J., Barcenilla, H., Swank, Z., Zuo, F., Abolhassani, H., Pavlovitch-Bedzyk, A. J., Wang, C., Gonzalez, L., Habimana Mugabo, C., Johnsson, A., Chen, Y., James, A., Mikes, J., Kleberg, L., Sundling, C., Bjornson, M., Nygren-Bonnier, M., Stahlberg, M., Runold, M., Bjorkander, S., Melen, E., Meyts, I., Van Weyenbergh, J., Hammarstrom, Q. P., Davis, M. M., Walt, D. R., Landegren, N., COVID Human Genetic Effort, , Aiuti, A., Casari, G., Casanova, J.-L., JAMOULLE, M., Bruchfeld, J., Brodin, P.
10.1101/2024.02.11.24302636 — Posted: 2024-02-13
Host-Microbe Multiomic Profiling Reveals Age-Dependent COVID-19 Immunopathology
Phan, H. V., Tstisiklis, A., Maguire, C. P., Haddad, E. K., Becker, P. M., Kim-Schulze, S., Lee, B., Chen, J., Hoch, A., Pickering, H., Van Zalm, P., Altman, M. C., Augustine, A. D., Calfee, C. S., Bosinger, S., Cairns, C., Eckalbar, W., Guan, L., Jayavelu, N. D., Kleinstein, S. H., Krammer, F., Maecker, H. T., Ozonoff, A., Peters, B., Rouphael, N., IMPACC Network, , Montgomery, R. R., Reed, E., Schaenman, J., Steen, H., Levy, O., Arce, J. D., Langelier, C. R.
10.1101/2024.02.11.24301704 — Posted: 2024-02-13
Analysis of signs and symptoms of SARS-CoV-2 virus infection considering different waves using Machine Learning
Ulrichsen, F. C., da Costa Sena, A., Figueiredo, K., Porto, L. C.
10.1101/2024.02.12.24302722 — Posted: 2024-02-13
Long-term cardiovascular safety of COVID-19 vaccination according to brand, dose and combinations: Cohort study of 46 million adults in England
Ip, S. H. Y., North, T.-L., Torabi, F., Li, Y., Abbasizanjani, H., Akbari, A., Horne, E. M. F., Denholm, R., Keene, S., Denaxas, S., Banerjee, A., Khunti, K., Sudlow, C., Whiteley, W., Sterne, J. A. C., Wood, A., Walker, V.
10.1101/2024.02.12.24302698 — Posted: 2024-02-13
A Phase II Study Integrating a Single-Blind Safety Phase with a Double-Blind, Placebo-Controlled Randomized Phase, Assessing Single-Dose Intramuscular or Intranasal Administration to Evaluate the Safety and Immunogenicity of the Recombinant Vaccine Against COVID-19 (AVX/COVID-12 "Patria") Based on an Active Newcastle Disease Viral Vector as a Heterologous Booster in Subjects with Evidence of Previous Immunity to SARS-CoV-2.
Lopez-Macias, C., Torres, M., Armenta-Copca, B., Wacher, N. H., Castro-Castrezana, L., Colli-Dominguez, A. A., Rivera-Hernandez, T., Torres-Flores, A., Ramirez-Martinez, L., Paz-De la Rosa, G., Rojas-Martinez, O., Suarez-Martinez, J. A., Peralta-Sanchez, G., Carranza, C., Juarez, E., Zamudio-Meza, H., Carreto-Binaghi, L. E., Viettri, M., Romero-Rodriguez, D., Palencia, A., Reyna-Rosas, E., Marquez-Garcia, J. E., Sarfati-Mizrahi, D., Sun, W., Chagoya-Cortes, H. E., Castro-Peralta, F., Palese, P., Krammer, F., Garcia-Sastre, A., Lozano-Dubernard, B.
10.1101/2024.02.11.24302594 — Posted: 2024-02-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).